Low
Good (70 to 90%)
$0.08 (PO)
$85.80 (IV)
Urinary tract infections
Susceptible MRSA infections
Stenotrophomonas infections
Pneumocystis jirovecii pneumonia (Treatment or prophylaxis)
Follow creatinine and electrolytes in patients at increased risk renal failure, hyperkalemia.
Gastrointestinal upset common
Bone marrow suppression
Hyperkalemia
Renal failure
Hepatitis
Aseptic meningitis
Stevens Johnson syndrome/toxic epidermal necrolysis
Other rashes
ACEi - Increased serum potassium level
Increases amantadine levels
Decreases cyclosporine
Methotrexate - Marrow suppression
Increases phenytoin
Increases rifampin
Increases INR with warfarin
IV Administration
Dilute each 5mL amp in 100-125 mL NS or D5W. Administer dose over 60-90 min.
May dilute each 5 mL amp in 50-75 mL if fluid restricted but stability may be markedly decreased
Each 5 mL ampoule contains:
80 mg Trimethoprim
400 mg Sulfamethoxazole
Each single strength (SS) tablet contains:
80 mg Trimethoprim
400 mg Sulfamethoxazole
Each double strength (DS) tablet contains:
160mg Trimethoprim
800 mg Sulfamethoxazole
EH prescribing restrictions
None
Community IV Formulary (Metro Area)
NO
Tablets may be crushed for NG administration; Liquid formulation is also available.
10mL Oral liquid = 1 single strength (SS) tablet
20mL Oral liquid = 1 double strength (DS) tablet
Antimicrobial class: Sulfonamide - Antifolate
Pregnancy category: C
Average serum half life: 10 hours
Biliary penetration: Moderate
CSF penetration: Therapeutic
Lung penetration: Therapeutic
Urine penetration: Therapeutic